Therapeutic drug monitoring in children and adolescents: findings on fluoxetine from the TDM-VIGIL trial

Fluoxetine is the recommended first-line antidepressant in many therapeutic guidelines for children and adolescents. However, little is known about the relationships between drug dose and serum level as well as the therapeutic serum reference range in this age group. Within a large naturalistic obse...

Full description

Saved in:
Bibliographic Details
Main Authors: Frey, Michael (Author) , Smigielski, Lukasz (Author) , Tini, Elvira (Author) , Fekete, Stefanie (Author) , Fleischhaker, Christian (Author) , Wewetzer, Christoph (Author) , Karwautz, Andreas (Author) , Correll, Christoph U. (Author) , Gerlach, Manfred (Author) , Taurines, Regina (Author) , Plener, Paul L. (Author) , Malzahn, Uwe (Author) , Kornbichler, Selina (Author) , Weninger, Laura (Author) , Brockhaus, Matthias (Author) , Reuter-Dang, Su-Yin (Author) , Reitzle, Karl (Author) , Rock, Hans (Author) , Imgart, Hartmut (Author) , Heuschmann, Peter (Author) , Unterecker, Stefan (Author) , Briegel, Wolfgang (Author) , Banaschewski, Tobias (Author) , Fegert, Jörg M. (Author) , Hellenschmidt, Tobias (Author) , Kaess, Michael (Author) , Kölch, Michael (Author) , Renner, Tobias (Author) , Rexroth, Christian (Author) , Walitza, Susanne (Author) , Schulte-Körne, Gerd (Author) , Romanos, Marcel (Author) , Egberts, Karin M. (Author)
Format: Article (Journal)
Language:English
Published: 25 August 2023
In: Pharmaceutics
Year: 2023, Volume: 15, Issue: 9, Pages: 1-19
ISSN:1999-4923
DOI:10.3390/pharmaceutics15092202
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.3390/pharmaceutics15092202
Verlag, kostenfrei, Volltext: https://www.mdpi.com/1999-4923/15/9/2202
Get full text
Author Notes:Michael Frey, Lukasz Smigielski, Elvira Tini, Stefanie Fekete, Christian Fleischhaker, Christoph Wewetzer, Andreas Karwautz, Christoph U. Correll, Manfred Gerlach, Regina Taurines, Paul L. Plener, Uwe Malzahn, Selina Kornbichler, Laura Weninger, Matthias Brockhaus, Su-Yin Reuter-Dang, Karl Reitzle, Hans Rock, Hartmut Imgart, Peter Heuschmann, Stefan Unterecker, Wolfgang Briegel, Tobias Banaschewski, Jörg M. Fegert, Tobias Hellenschmidt, Michael Kaess, Michael Kölch, Tobias Renner, Christian Rexroth, Susanne Walitza, Gerd Schulte-Körne, Marcel Romanos and Karin Maria Egberts

MARC

LEADER 00000caa a2200000 c 4500
001 1873113293
003 DE-627
005 20250115024140.0
007 cr uuu---uuuuu
008 231212s2023 xx |||||o 00| ||eng c
024 7 |a 10.3390/pharmaceutics15092202  |2 doi 
035 |a (DE-627)1873113293 
035 |a (DE-599)KXP1873113293 
035 |a (OCoLC)1425208243 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Frey, Michael  |e VerfasserIn  |0 (DE-588)1167545125  |0 (DE-627)1031165630  |0 (DE-576)511187726  |4 aut 
245 1 0 |a Therapeutic drug monitoring in children and adolescents  |b findings on fluoxetine from the TDM-VIGIL trial  |c Michael Frey, Lukasz Smigielski, Elvira Tini, Stefanie Fekete, Christian Fleischhaker, Christoph Wewetzer, Andreas Karwautz, Christoph U. Correll, Manfred Gerlach, Regina Taurines, Paul L. Plener, Uwe Malzahn, Selina Kornbichler, Laura Weninger, Matthias Brockhaus, Su-Yin Reuter-Dang, Karl Reitzle, Hans Rock, Hartmut Imgart, Peter Heuschmann, Stefan Unterecker, Wolfgang Briegel, Tobias Banaschewski, Jörg M. Fegert, Tobias Hellenschmidt, Michael Kaess, Michael Kölch, Tobias Renner, Christian Rexroth, Susanne Walitza, Gerd Schulte-Körne, Marcel Romanos and Karin Maria Egberts 
264 1 |c 25 August 2023 
300 |b Illustrationen 
300 |a 19 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Veröffentlicht: 25. August 2023 
500 |a Gesehen am 12.12.2023 
520 |a Fluoxetine is the recommended first-line antidepressant in many therapeutic guidelines for children and adolescents. However, little is known about the relationships between drug dose and serum level as well as the therapeutic serum reference range in this age group. Within a large naturalistic observational prospective multicenter clinical trial (“TDM-VIGIL”), a transdiagnostic sample of children and adolescents (n = 138; mean age, 15; range, 7-18 years; 24.6% males) was treated with fluoxetine (10-40 mg/day). Analyses of both the last timepoint and all timepoints (n = 292 observations), utilizing (multiple) linear regressions, linear mixed-effect models, and cumulative link (mixed) models, were used to test the associations between dose, serum concentration, outcome, and potential predictors. The receiver operating curve and first to third interquartile methods, respectively, were used to examine concentration cutoff and reference values for responders. A strong positive relationship was found between dose and serum concentration of fluoxetine and its metabolite. Higher body weight was associated with lower serum concentrations, and female sex was associated with lower therapeutic response. The preliminary reference ranges for the active moiety (fluoxetine+norfluoxetine) were 208-328 ng/mL (transdiagnostically) and 201.5-306 ng/mL (depression). Most patients showed marked (45.6%) or minimal (43.5%) improvements and reported no adverse effects (64.9%). This study demonstrated a clear linear dose-serum level relationship for fluoxetine in youth, with the identified reference range being within that established for adults. 
650 4 |a adolescents 
650 4 |a antidepressants 
650 4 |a depression 
650 4 |a pharmacovigilance 
650 4 |a reference range 
650 4 |a selective serotonin reuptake inhibitors 
650 4 |a steady-state concentration 
650 4 |a TDM 
700 1 |a Smigielski, Lukasz  |e VerfasserIn  |4 aut 
700 1 |a Tini, Elvira  |e VerfasserIn  |4 aut 
700 1 |a Fekete, Stefanie  |e VerfasserIn  |4 aut 
700 1 |8 1\p  |a Fleischhaker, Christian  |e VerfasserIn  |0 (DE-588)114863342  |0 (DE-627)621546917  |0 (DE-576)17733679X  |4 aut 
700 1 |a Wewetzer, Christoph  |e VerfasserIn  |4 aut 
700 1 |a Karwautz, Andreas  |e VerfasserIn  |4 aut 
700 1 |a Correll, Christoph U.  |e VerfasserIn  |4 aut 
700 1 |a Gerlach, Manfred  |e VerfasserIn  |4 aut 
700 1 |a Taurines, Regina  |e VerfasserIn  |4 aut 
700 1 |a Plener, Paul L.  |e VerfasserIn  |4 aut 
700 1 |a Malzahn, Uwe  |e VerfasserIn  |4 aut 
700 1 |a Kornbichler, Selina  |e VerfasserIn  |4 aut 
700 1 |a Weninger, Laura  |e VerfasserIn  |4 aut 
700 1 |a Brockhaus, Matthias  |e VerfasserIn  |4 aut 
700 1 |a Reuter-Dang, Su-Yin  |e VerfasserIn  |4 aut 
700 1 |a Reitzle, Karl  |e VerfasserIn  |4 aut 
700 1 |a Rock, Hans  |e VerfasserIn  |4 aut 
700 1 |a Imgart, Hartmut  |e VerfasserIn  |4 aut 
700 1 |a Heuschmann, Peter  |e VerfasserIn  |4 aut 
700 1 |a Unterecker, Stefan  |e VerfasserIn  |4 aut 
700 1 |a Briegel, Wolfgang  |e VerfasserIn  |4 aut 
700 1 |a Banaschewski, Tobias  |d 1961-  |e VerfasserIn  |0 (DE-588)115856110  |0 (DE-627)507227301  |0 (DE-576)178364703  |4 aut 
700 1 |a Fegert, Jörg M.  |e VerfasserIn  |4 aut 
700 1 |a Hellenschmidt, Tobias  |e VerfasserIn  |4 aut 
700 1 |a Kaess, Michael  |d 1979-  |e VerfasserIn  |0 (DE-588)136367240  |0 (DE-627)694324248  |0 (DE-576)300984766  |4 aut 
700 1 |a Kölch, Michael  |e VerfasserIn  |4 aut 
700 1 |a Renner, Tobias  |e VerfasserIn  |4 aut 
700 1 |a Rexroth, Christian  |e VerfasserIn  |4 aut 
700 1 |a Walitza, Susanne  |e VerfasserIn  |4 aut 
700 1 |a Schulte-Körne, Gerd  |e VerfasserIn  |4 aut 
700 1 |a Romanos, Marcel  |e VerfasserIn  |4 aut 
700 1 |8 2\p  |a Egberts, Karin M.  |e VerfasserIn  |0 (DE-588)1303833786  |0 (DE-627)1860204929  |4 aut 
773 0 8 |i Enthalten in  |t Pharmaceutics  |d Basel : MDPI, 2009  |g 15(2023), 9, Artikel-ID 2202, Seite 1-19  |h Online-Ressource  |w (DE-627)614096529  |w (DE-600)2527217-2  |w (DE-576)313958653  |x 1999-4923  |7 nnas  |a Therapeutic drug monitoring in children and adolescents findings on fluoxetine from the TDM-VIGIL trial 
773 1 8 |g volume:15  |g year:2023  |g number:9  |g elocationid:2202  |g pages:1-19  |g extent:19  |a Therapeutic drug monitoring in children and adolescents findings on fluoxetine from the TDM-VIGIL trial 
856 4 0 |u https://doi.org/10.3390/pharmaceutics15092202  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.mdpi.com/1999-4923/15/9/2202  |x Verlag  |z kostenfrei  |3 Volltext 
883 |8 1\p  |a cgwrk  |d 20241001  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
883 |8 2\p  |a cgwrk  |d 20241001  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
951 |a AR 
992 |a 20231212 
993 |a Article 
994 |a 2023 
998 |g 136367240  |a Kaess, Michael  |m 136367240:Kaess, Michael  |d 910000  |d 910600  |e 910000PK136367240  |e 910600PK136367240  |k 0/910000/  |k 1/910000/910600/  |p 26 
998 |g 115856110  |a Banaschewski, Tobias  |m 115856110:Banaschewski, Tobias  |d 60000  |e 60000PB115856110  |k 0/60000/  |p 23 
999 |a KXP-PPN1873113293  |e 4431100466 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"note":["Veröffentlicht: 25. August 2023","Gesehen am 12.12.2023"],"relHost":[{"title":[{"title":"Pharmaceutics","title_sort":"Pharmaceutics"}],"part":{"pages":"1-19","year":"2023","issue":"9","text":"15(2023), 9, Artikel-ID 2202, Seite 1-19","extent":"19","volume":"15"},"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.2009 -"],"name":{"displayForm":["Molecular Diversity Preservation International"]},"recId":"614096529","id":{"eki":["614096529"],"zdb":["2527217-2"],"issn":["1999-4923"]},"disp":"Therapeutic drug monitoring in children and adolescents findings on fluoxetine from the TDM-VIGIL trialPharmaceutics","language":["eng"],"note":["Gesehen am 28.05.14"],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedKey":"2009","publisherPlace":"Basel","dateIssuedDisp":"2009-","publisher":"MDPI"}]}],"physDesc":[{"extent":"19 S.","noteIll":"Illustrationen"}],"origin":[{"dateIssuedKey":"2023","dateIssuedDisp":"25 August 2023"}],"title":[{"title_sort":"Therapeutic drug monitoring in children and adolescents","title":"Therapeutic drug monitoring in children and adolescents","subtitle":"findings on fluoxetine from the TDM-VIGIL trial"}],"person":[{"role":"aut","roleDisplay":"VerfasserIn","given":"Michael","display":"Frey, Michael","family":"Frey"},{"role":"aut","family":"Smigielski","display":"Smigielski, Lukasz","roleDisplay":"VerfasserIn","given":"Lukasz"},{"family":"Tini","roleDisplay":"VerfasserIn","display":"Tini, Elvira","given":"Elvira","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","given":"Stefanie","display":"Fekete, Stefanie","family":"Fekete"},{"family":"Fleischhaker","display":"Fleischhaker, Christian","roleDisplay":"VerfasserIn","given":"Christian","role":"aut"},{"given":"Christoph","roleDisplay":"VerfasserIn","display":"Wewetzer, Christoph","family":"Wewetzer","role":"aut"},{"roleDisplay":"VerfasserIn","given":"Andreas","display":"Karwautz, Andreas","family":"Karwautz","role":"aut"},{"role":"aut","family":"Correll","display":"Correll, Christoph U.","roleDisplay":"VerfasserIn","given":"Christoph U."},{"role":"aut","family":"Gerlach","display":"Gerlach, Manfred","roleDisplay":"VerfasserIn","given":"Manfred"},{"display":"Taurines, Regina","roleDisplay":"VerfasserIn","given":"Regina","family":"Taurines","role":"aut"},{"role":"aut","display":"Plener, Paul L.","roleDisplay":"VerfasserIn","given":"Paul L.","family":"Plener"},{"role":"aut","family":"Malzahn","given":"Uwe","roleDisplay":"VerfasserIn","display":"Malzahn, Uwe"},{"role":"aut","display":"Kornbichler, Selina","roleDisplay":"VerfasserIn","given":"Selina","family":"Kornbichler"},{"role":"aut","display":"Weninger, Laura","roleDisplay":"VerfasserIn","given":"Laura","family":"Weninger"},{"family":"Brockhaus","roleDisplay":"VerfasserIn","given":"Matthias","display":"Brockhaus, Matthias","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Reuter-Dang, Su-Yin","given":"Su-Yin","family":"Reuter-Dang"},{"role":"aut","roleDisplay":"VerfasserIn","given":"Karl","display":"Reitzle, Karl","family":"Reitzle"},{"family":"Rock","given":"Hans","roleDisplay":"VerfasserIn","display":"Rock, Hans","role":"aut"},{"role":"aut","family":"Imgart","given":"Hartmut","roleDisplay":"VerfasserIn","display":"Imgart, Hartmut"},{"role":"aut","family":"Heuschmann","given":"Peter","roleDisplay":"VerfasserIn","display":"Heuschmann, Peter"},{"family":"Unterecker","given":"Stefan","roleDisplay":"VerfasserIn","display":"Unterecker, Stefan","role":"aut"},{"family":"Briegel","roleDisplay":"VerfasserIn","display":"Briegel, Wolfgang","given":"Wolfgang","role":"aut"},{"role":"aut","display":"Banaschewski, Tobias","roleDisplay":"VerfasserIn","given":"Tobias","family":"Banaschewski"},{"given":"Jörg M.","roleDisplay":"VerfasserIn","display":"Fegert, Jörg M.","family":"Fegert","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","given":"Tobias","display":"Hellenschmidt, Tobias","family":"Hellenschmidt"},{"family":"Kaess","display":"Kaess, Michael","roleDisplay":"VerfasserIn","given":"Michael","role":"aut"},{"role":"aut","display":"Kölch, Michael","roleDisplay":"VerfasserIn","given":"Michael","family":"Kölch"},{"role":"aut","family":"Renner","roleDisplay":"VerfasserIn","display":"Renner, Tobias","given":"Tobias"},{"role":"aut","family":"Rexroth","roleDisplay":"VerfasserIn","given":"Christian","display":"Rexroth, Christian"},{"role":"aut","display":"Walitza, Susanne","roleDisplay":"VerfasserIn","given":"Susanne","family":"Walitza"},{"display":"Schulte-Körne, Gerd","roleDisplay":"VerfasserIn","given":"Gerd","family":"Schulte-Körne","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Romanos, Marcel","given":"Marcel","family":"Romanos","role":"aut"},{"role":"aut","family":"Egberts","display":"Egberts, Karin M.","roleDisplay":"VerfasserIn","given":"Karin M."}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"name":{"displayForm":["Michael Frey, Lukasz Smigielski, Elvira Tini, Stefanie Fekete, Christian Fleischhaker, Christoph Wewetzer, Andreas Karwautz, Christoph U. Correll, Manfred Gerlach, Regina Taurines, Paul L. Plener, Uwe Malzahn, Selina Kornbichler, Laura Weninger, Matthias Brockhaus, Su-Yin Reuter-Dang, Karl Reitzle, Hans Rock, Hartmut Imgart, Peter Heuschmann, Stefan Unterecker, Wolfgang Briegel, Tobias Banaschewski, Jörg M. Fegert, Tobias Hellenschmidt, Michael Kaess, Michael Kölch, Tobias Renner, Christian Rexroth, Susanne Walitza, Gerd Schulte-Körne, Marcel Romanos and Karin Maria Egberts"]},"recId":"1873113293","id":{"doi":["10.3390/pharmaceutics15092202"],"eki":["1873113293"]}} 
SRT |a FREYMICHAETHERAPEUTI2520